These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 27613562)

  • 41. Underperformance of clinical risk scores in identifying vascular ultrasound-based high cardiovascular risk in systemic lupus erythematosus.
    Drosos GC; Konstantonis G; Sfikakis PP; Tektonidou MG
    Eur J Prev Cardiol; 2021 Apr; 28(3):346-352. PubMed ID: 33891687
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardiovascular risk model performance in women with and without hypertensive disorders of pregnancy.
    Dam V; Onland-Moret NC; Verschuren WMM; Boer JMA; Benschop L; Franx A; Moons KGM; Boersma E; van der Schouw YT;
    Heart; 2019 Feb; 105(4):330-336. PubMed ID: 30209122
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Validation of the general Framingham Risk Score (FRS), SCORE2, revised PCE and WHO CVD risk scores in an Asian population.
    Kasim SS; Ibrahim N; Malek S; Ibrahim KS; Aziz MF; Song C; Chia YC; Ramli AS; Negishi K; Mat Nasir N
    Lancet Reg Health West Pac; 2023 Jun; 35():100742. PubMed ID: 37424687
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardiovascular disease risk prediction equations in 400 000 primary care patients in New Zealand: a derivation and validation study.
    Pylypchuk R; Wells S; Kerr A; Poppe K; Riddell T; Harwood M; Exeter D; Mehta S; Grey C; Wu BP; Metcalf P; Warren J; Harrison J; Marshall R; Jackson R
    Lancet; 2018 May; 391(10133):1897-1907. PubMed ID: 29735391
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk of coronary artery disease in individuals infected with human immunodeficiency virus.
    Vilela FD; Lorenzo AR; Tura BR; Ferraiuoli GI; Hadlich M; Barros MV; Lima AB; Meirelles V
    Braz J Infect Dis; 2011; 15(6):521-7. PubMed ID: 22218509
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Distribution and Performance of Cardiovascular Risk Scores in a Mixed Population of HIV-Infected and Community-Based HIV-Uninfected Individuals in Uganda.
    Muiru AN; Bibangambah P; Hemphill L; Sentongo R; Kim JH; Triant VA; Bangsberg DR; Tsai AC; Martin JN; Haberer JE; Boum Y; Plutzky J; Hunt PW; Okello S; Siedner MJ
    J Acquir Immune Defic Syndr; 2018 Aug; 78(4):458-464. PubMed ID: 29652762
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Validation of Risk Prediction Models for Atherosclerotic Cardiovascular Disease in a Prospective Korean Community-Based Cohort.
    Bae JH; Moon MK; Oh S; Koo BK; Cho NH; Lee MK
    Diabetes Metab J; 2020 Jun; 44(3):458-469. PubMed ID: 31950769
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nonconcordance between subclinical atherosclerosis and the calculated Framingham risk score in HIV-infected patients: relationships with serum markers of oxidation and inflammation.
    Parra S; Coll B; Aragonés G; Marsillach J; Beltrán R; Rull A; Joven J; Alonso-Villaverde C; Camps J
    HIV Med; 2010 Apr; 11(4):225-31. PubMed ID: 19845792
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of different cardiovascular risk tools used in HIV patient cohorts in sub-Saharan Africa; do we need to include laboratory tests?
    Mubiru F; Castelnuovo B; Reynolds SJ; Kiragga A; Tibakabikoba H; Owarwo NC; Kambugu A; Lamorde M; Parkes-Ratanshi R
    PLoS One; 2021; 16(1):e0243552. PubMed ID: 33507945
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cardiovascular risk assessment in persons with HIV infection in the developing world: comparing three risk equations in a cohort of HIV-infected Thais.
    Edwards-Jackson N; Kerr S; Tieu H; Ananworanich J; Hammer S; Ruxrungtham K; Phanuphak P; Avihingsanon A;
    HIV Med; 2011 Sep; 12(8):510-5. PubMed ID: 21375686
    [TBL] [Abstract][Full Text] [Related]  

  • 51. External validation of two Framingham cardiovascular risk equations and the Pooled Cohort equations: A nationwide registry analysis.
    Wallisch C; Heinze G; Rinner C; Mundigler G; Winkelmayer WC; Dunkler D
    Int J Cardiol; 2019 May; 283():165-170. PubMed ID: 30429082
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cardiovascular disease risk prediction in sub-Saharan African populations - Comparative analysis of risk algorithms in the RODAM study.
    Boateng D; Agyemang C; Beune E; Meeks K; Smeeth L; Schulze MB; Addo J; de-Graft Aikins A; Galbete C; Bahendeka S; Danquah I; Agyei-Baffour P; Owusu-Dabo E; Mockenhaupt FP; Spranger J; Kengne AP; Grobbee DE; Klipstein-Grobusch K
    Int J Cardiol; 2018 Mar; 254():310-315. PubMed ID: 29407113
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiovascular Risk in HIV-Infected and Uninfected Postmenopausal Minority Women: Use of the Framingham Risk Score.
    Cortés YI; Reame N; Zeana C; Jia H; Ferris DC; Shane E; Yin MT
    J Womens Health (Larchmt); 2017 Mar; 26(3):241-248. PubMed ID: 27611626
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identifying HIV patients with an unfavorable cardiovascular risk profile in the clinical practice: results from the SIMONE study.
    De Socio GV; Parruti G; Quirino T; Ricci E; Schillaci G; Adriani B; Marconi P; Franzetti M; Martinelli C; Vichi F; Penco G; Sfara C; Madeddu G; Bonfanti P;
    J Infect; 2008 Jul; 57(1):33-40. PubMed ID: 18436307
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cardiovascular disease risk scores' relationship to subclinical cardiovascular disease among HIV-infected and HIV-uninfected men.
    Monroe AK; Haberlen SA; Post WS; Palella FJ; Kinsgley LA; Witt MD; Budoff M; Jacobson LP; Brown TT
    AIDS; 2016 Aug; 30(13):2075-84. PubMed ID: 27203714
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is estimated cardiovascular risk higher in HIV-infected patients than in the general population?
    De Socio GV; Martinelli L; Morosi S; Fiorio M; Roscini AR; Stagni G; Schillaci G
    Scand J Infect Dis; 2007; 39(9):805-12. PubMed ID: 17701720
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Validation of the pooled cohort risk score in an Asian population - a retrospective cohort study.
    Chia YC; Lim HM; Ching SM
    BMC Cardiovasc Disord; 2014 Nov; 14():163. PubMed ID: 25410585
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk of cardiovascular disease associated with HCV and HBV coinfection among antiretroviral-treated HIV-infected individuals.
    Gillis J; Smieja M; Cescon A; Rourke SB; Burchell AN; Cooper C; Raboud JM;
    Antivir Ther; 2014; 19(3):309-17. PubMed ID: 24429380
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Presence of the metabolic syndrome is not a better predictor of cardiovascular disease than the sum of its components in HIV-infected individuals: data collection on adverse events of anti-HIV drugs (D:A:D) study.
    Worm SW; Sabin CA; Reiss P; El-Sadr W; Monforte Ad; Pradier C; Thiebaut R; Law M; Rickenbach M; De Wit S; Lundgren JD; Friis-Møller N
    Diabetes Care; 2009 Mar; 32(3):474-80. PubMed ID: 19056612
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Level of agreement between frequently used cardiovascular risk calculators in people living with HIV.
    Dhillon S; Sabin CA; Alagaratnam J; Bagkeris E; Post FA; Boffito M; Anderson J; Vera J; Williams I; Johnson M; Sachikonye M; Babalis D; Mallon PW; Winston A;
    HIV Med; 2019 May; 20(5):347-352. PubMed ID: 30873751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.